State-based Reform
-
Affordable Care Act, Caught my eye, Employers, Healthcare Costs, Medicaid, Medicare Part D, Pharmacy Benefit Managers, Reference Pricing, State-based Reform, Utilization ManagementAMP is WAC — 9/19/25
Read more: AMP is WAC — 9/19/25Work travel is usually a nice change of pace. And then I found myself on a Wednesday afternoon on the NJ Turnpike in torrential rain with other cars facing the wrong direction. Super fun! Two good things – 1) the pharma team I gave the talk to was awesome and 2) made it home safe…
-
Inflation Reduction Act, Medicare Advantage, Medicare Part D, Reference Pricing, State-based Reform, Supply Chain, VaccinesAMP is WAC — 8/15/25
Read more: AMP is WAC — 8/15/25Caught my Eye Surely a Coincidence. President Trump called for direct to consumer purchasing at Most Favored Nation Pricing and BlinkRx said that they could offer this service. Donald Trump Jr. is on their board. Lobby Me This. Stat News had an article about a new coalition, IRA Watch, that is formed to discuss…
-
Solving for Access and Affordability: PDABs are not the Answer
Read more: Solving for Access and Affordability: PDABs are not the AnswerToday a paper I’ve been working on for a while with the Rare Access Action Project (RAAP) is unleashed — well timed for NCSL in Boston. It isn’t that prescription drug affordability boards (PDABs) are bad, I just don’t think they can meet their objectives. I’m excited for this paper to come out highlighting why…
-
AMP is WAC — 06/20/25
Read more: AMP is WAC — 06/20/25All the summer Friday vibes today, including a cocktail in mind for later. I’ve been trying to top the Paper Plane and the Broken Plane is close. Any other recs, let me know. In the meantime, to-do list in hand and ready to hit the ground running. Caught my Eye Hit Us with Your Best…
-
340B, Caught my eye, COVID, Drug Prices, Medicaid, Medicare Negotiation, Medicare Part D, Medicare Transaction Facilitator, Pharmacy Benefit Managers, Reference Pricing, State-based Reform, VaccinesAMP is WAC — 05/30/25
Read more: AMP is WAC — 05/30/25I do love a Monday off. It somehow feels like an a double-treat – you get the Monday off and the week flies by. Yes we had to cram more meetings and work into the shorter week but totally worth it. Caught my Eye Processed Over. This week the Secretary of Health and Human Services,…
-
340B, Alzheimer’s, Biosimilars, Caught my eye, Drug Prices, Generics, Healthcare Costs, Importation, Medicaid, State-based ReformAMP is WAC — 05/23/25
Read more: AMP is WAC — 05/23/25It’s the Friday of Memorial Day weekend, let’s blow this pop (pup?) stand. I’m playing with the format of these posts so let me know what you think. The aim is to be more of a newsletter than a blog, but still give you everything you need to know in just a few minutes a…
-
340B, Caught my eye, Inflation Reduction Act, Medicare Negotiation, Medicare Part D, Pharmacy Benefit Managers, State-based ReformCaught my eye — 4/25/25
Read more: Caught my eye — 4/25/25Let’s Get Horizontal. Arkansas just passed a law banning pharmacy benefit managers (PBMs) from owning pharmacies in the state. Other states like Vermont and New York are considering it. This also includes mail order and specialty pharmacy. Lately the economics of independent pharmacies are getting covered in the media showcasing how they often lose money…
-
340B, Caught my eye, Drug Prices, Inflation Reduction Act, Medicare Negotiation, Medicare Transaction Facilitator, Medicare Transaction Facilitator, Pharmacy Benefit Managers, State-based Reform, UncategorizedCaught my eye — 4/4/25
Read more: Caught my eye — 4/4/25Mom and Pop Going Broke. The economics of pharmacies are fascinating. Like did you know they usually lose money on brand-name drugs? A pharmacy benefit manager (PBM) law in Montana would help those pharmacies get closer to at least breaking even and make sure they get dispensing fees. I thought this KFF piece was a…
-
Caught my eye, Generics, Healthcare Costs, ICER, Inflation Reduction Act, Medicaid, Medicare Negotiation, Medicare Part D, Orphan Drugs, State-based Reform, ValueCaught my eye — 03/07/25
Read more: Caught my eye — 03/07/25Tuesday morning, I spent the first half of the day convinced it was Wednesday, and yet, despite that mental setback, the rest of the week has flown by. Feels like a win. Killing me softly. Overall, glad to see the stories recognizing how the uncertainty of federal research dollars is impacting NIH summer internships, graduate…
-
Caught my eye — 10/25/24
Read more: Caught my eye — 10/25/24Caught my eye .. This week I am struck by connections between 340B and pharmacy benefit managers (PBMs) in terms of being issue areas that need complete makeovers. A glow up won’t do; we’re beyond that. But the trajectory toward change is very different. PBMs and payers (maybe) benefit from the way PBMs currently work.…
Latest news
- AMP is WAC — 04/24/26
- AMP is WAC — 04/10/26
- AMP is WAC — 03/27/26
- AMP is WAC — 03/20/26
- AMP is WAC — 03/13/26
Categories
- 340B (64)
- Affordable Care Act (23)
- Alzheimer's (11)
- Biosimilars (33)
- Caught my eye (102)
- Cell and Gene (8)
- Chevron Deference (2)
- CMMI (29)
- Copay Accumulators (7)
- COVID (3)
- Drug Prices (58)
- Drug shortages (15)
- DTC (9)
- Employers (20)
- FDA (8)
- Generics (13)
- Health Equity (4)
- Healthcare Costs (41)
- Home Health (1)
- ICER (12)
- Importation (5)
- Inflation Reduction Act (69)
- Insulin (7)
- IP (3)
- Long term care (1)
- Medicaid (24)
- Medicare Advantage (27)
- Medicare Negotiation (68)
- Medicare Part D (78)
- Medicare Transaction Facilitator (5)
- Medicare Transaction Facilitator (12)
- Obesity (28)
- On the Horizon (1)
- Orphan Drugs (8)
- Pharmacy Benefit Managers (49)
- Preventative (5)
- Reference Pricing (26)
- State-based Reform (32)
- Supply Chain (8)
- Tariffs (2)
- Uncategorized (9)
- Utilization Management (14)
- Vaccines (10)
- Value (18)